Brevet nevalabil


(11)Number of the document1224
(21)Number of the application95-0086
(22)Filing date of the application1992.01.03
 Date of filing the request for examination (de fond) 18.06.1997
(71)Name(s) of applicant(s), code of the countryBIOCHEM PHARMA INC., CA;
(72)Name(s) of inventor(s), code of the countryBELLEAU Bernard, CA; NGUYEN-BA Nghe, CA;
(73)Name(s) of owner(s), code of the countrySHIRE CANADA INC, CA;
(54)Title of the inventionApplication of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B  
(13)Kind-of-document code
C2, BOPI 12/1999
B2, BOPI 05/1999
A, BOPI 01/1997
(51)International Patent Classification A61K 31/505 (2006.01);
(19)CountryCA
(41)Date of publication of the application1997.01.31
(45)Date of publication of patent granting decision:1999.05.31
(47)Date of issuance of patent1999.11.30
(30)Priority9100039.8, 1991.01.03, GB; 9109913,5, 1991.05.07, GB
(74)Patent attorneyJENICICOVSCAIA Galina, Str. Miron Costin nr. 15/2, of. 19-20, MD-2045, Chişinău, Republica Moldova
(85)Date of introducing the national procedure1994.11.30
(86)International applicationPCT/CA1992/000001, 1992.01.03
(87)International publicationWO 1992/11852, 1992.07.23
 Expired patents; Date of expiration2013.01.31
 Payment for maintenance up to the date2012.01.03
 Change of the owner
Nr. şi data deciziei:6386, 2009.06.16
Datele iniţiale:BIOCHEM PHARMA INC., CA; 275 Armand Frappier Boulevard, Laval, Quebac H7V 4A7, Canada
Datele finale:SHIRE BIOCHEM INC., CA; 2250, Boul. Alfred-Nobel Bur. 500 Ville Saint-laurent Quebec H4S 2C9
Nr. şi data deciziei:6950, 2009.07.02
Datele iniţiale:SHIRE BIOCHEM INC., CA; 2250, Boul. Alfred-Nobel Bur. 500 Ville Saint-laurent Quebec H4S 2C9
Datele finale:SHIRE CANADA INC, CA; 2250, Boul. Alfred-Nobel Bur. 500 Ville Saint-Laurent Quebec H4S 2C9

11.08.2026